Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research
Discover AMSBIO’s optimized antibodies for stem cell research that offer high specificity, reproducibility, and validated purity for reliable results
The ORCA-Halo combines cutting-edge reliable technology with excellent image quality performance
A key focus of the partnership will be the development of adeno-associated virus gene therapy programs using intellectual property from KU Leuven
Logos Biosystems, SPT Labtech and BMG LABTECH among those recognized
Introducing Cheetah™ FLEX and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerases for qPCR, PEA, and NGS-based PEA workflows
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
From synthetic biology to microbiome and food safety research, the QPix FLEX system gives researchers the power to accelerate discovery, reduce hands-on time, and streamline their entire microbial screening process
Designed to enable scientists to conduct small-scale experiments quickly and affordably
Dr. Chia-Lin Wei, Professor of Genome Sciences at University of Washington, shares how to unlock DNA methylation insights for neuroscience and cancer research
Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress
As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease
A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival
Laboratory water quality is often overlooked but plays a pivotal role in ensuring accuracy, compliance, and reproducibility
Hear how researchers have discovered a new cellular mechanism that controls the stability of messenger RNA (mRNA) in cells
New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow
1 in 3 Phase II trials were terminated in 2024
The UG 100 offers a cost-effective and extremely low-error sequencing profile
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine
New test format enhances commercialisation potential
